Prevention of post-traumatic clinical capillary leak syndrome

Trauma

Volumn 1, Issue 2, 1999, Pages 91-103

  Gosling, Peter ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

clinical capillary leak syndrome; multiple organ failure; trauma

Indexed keywords

EID: 0002271061     PISSN: 14604086     EISSN: None     Source Type: Journal    
DOI: 10.1177/146040869900100201     Document Type: Article

References (58)

1. Agre P, Preston GM, Smith BL, Jung JS, Rana S, Moon C et al. Aquaporin CHIP: The archetypal molecular water channel. Am J Physiol 1993; 265: F463-F476.
2. Allison K, Gosling P, Gowar JP. Capillary permeability following HAS infusion. Proceedings of the British Burn Association Meeting. Sheffield, 1998.
3. Beyer R, Harmening U, Rittmeyer O, Zeilmann F, Mielck F, Kazmaier S, et al. Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery. Br J Anaesth 1997; 78: 44-50.
4. Boldt J, Heesen M, Muller M, Pabsdorf M, Hempelmann G. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Aesth Analg 1996; 83: 254-261.
5. Bowyer MW. Fluid therapy. In: Parsons PE, Wiener-Kronish JP eds. Critical care secrets. St Louis, MO; Mosby Year Book, 1992: 24-26.
6. Cittanova ML, Leblanc I, Legendre Ch, Mouquet C, Coriat P. Effect of hydroxyethyl starch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348: 1620-1622.
7. Davies MG, Hagen PO. Systemic inflammatory response syndrome. Br J Surg 1997; 84: 920-935.
8. Dick M, Dasta JF, Choban PS, Sinha R, Flancbaum L. Serum aldosterone concentrations and urine output in oliguric intensive care patients receiving low dose dopamine. Ann Pharmacother 1994; 28: 837-841.
9. Emminger W, Emminger-Schmidmeier W, Peters C, Susani M, Hawlickzek R, Hocker P, et al. Capillary leak syndrome during low dose granulocyte colony-stimulating factor (rh GM-CSF) treatment of a patient in a continuous febrile state. Blut 1990; 61: 219-221.
10. Ehringer WD, Edwards MJ, Miller FN. Mechanisms of alpha-thrombin, histamine and bradykinin induced endothelial permeability. J Cell Physiol 1996; 167: 562-569.
11. Fleck A, Raines G, Hawker F, Trotter J, Wallace PI, Ledingham IM, et al. Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1985; i: 781-784.
12. Forstermann U, Closs EI, Pollock JS. Nitric oxide synthase isoenzymes: characterisation, purification, molecular cloning, and functions. Hypertension 1994; 23: 1121-1131.
13. Fujishima S, Aikawa N. Neutrophil-mediated tissue injury and its modulation. Intensive Care Med 1995; 21: 277-285.
14. Gosling P. Microalbuminuria: a marker of systemic disease. Br J Hosp Med 1995; 54: 285-290.
15. Gosling P, Shearman CP, Gwynn BR, Simms MH, Bainbridge ET. Microproteinuria: response to operation. BMJ 1988(a); 296: 338-339.
16. Gosling P, Sutcliffe AJ, Cooper MACS, Jones AF. Burn and trauma associated proteinuria: the role of lipid peroxidation, renin and myoglobin. Ann Clin Biochem 1988(b); 25: 53-59.
17. Gosling P, Allison K, Pallister I, Bradley S, Porter K. Hydroxyethyl starch reduces capillary permeability and improves gas exchange in patients following major trauma. Proceedings of the National Meeting of the Association of Clinical Biochemists. Glasgow, 1998; 24-24.
18. Hack CE, Ogilvie AC, Eisele B, Eerenberg AJ, Wagstaff J, Thijis LG. C1-inhibitor therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Med 1993; 19(Suppl 1): S19-S28.
19. Hakaim AG, Cirsetti R, Cho SI. The pentafraction of hydro-xyethyl starch inhibits ischaemia induced compartment syndrome. J Trauma 1994; 37: 18-21.
20. Horton RC, Gosling P, Reeves CN, Payne M, Nagle RE. Microalbuminuria excretion in patients with positive exercise electrocardiogram tests. Eur Heart J 1994; 15: 1353-1355.
21. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Microalbuminaria reflects a generalised transvascular albumin leakiness in clinically healthy subjects. Clin Sci 1995; 88: 629-633.
22. Joris I, Majno G, Corey EJ. The mechanism of vascular leakage induced by leucotriene E4: endothelial cell contraction. Am J Path 1987; 126: 19-19.
23. Khaira HS, Nash GB, Bahra PS, Sanghera K, Gosling P, Crow AJ, et al. Thromboxane and neutrophil changes following intermittent claudication suggest ischaemia-reperfusion injury. Eur J Vasc Endovasc Surg 1995; 10(1): 31-35.
24. Klein N, Shennan G, Heyderman R, Levin M. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils. J Cell Sci 1992; 102: 821-832.
25. Kanwar YS. Biophysiology of glomerular filtration and proteinuria. Lab Invest 1984; 51: 7-21.
26. Kotasek D, Vercellotti GM, Ochoa AC, Bach FH, White JG, Jacob HS. Mechanism of cultured endothelial injury induced by lymphokine-activated killer cells. Cancer Res 1988; 48: 5528-5532.
27. J., Li, S., Gyorffy, S., Lee, C.S., Kwok, Effect of recombinant interleukin-2 on neutrophil adherence to endothelial cells in vitro, Inflammation, (1996), 29, 361-372
28. London MJ, Triedman JK, Verrier ED, Levin J, Merrick SH, Hanley FL et al. A randomised clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 1989: 785-797.
29. MacKinnon KL, Molnar Z, Watson ID, Shearer E, Lowe D. Use of microalbuminuria as an indicator for the development of sepsis and multiple organ failure. Br J Anaesth 1997: 678P-678P.
30. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
31. Mulligan MS, Schmid E, Beck-Schimmer B, Till GO, Freidl HP et al. Requirement and role of C5a in acute lung inflammatory injury in rats. J Clin Invest 1996; 98: 503-512.
32. Niimi N, Noso N, Yamamoto S. The effect of histamine on cultured endothelial cells. A study of the mechanism of increased permeability. Eur J Pharmacol 1992; 221: 325-331.
33. Nuytinck HKS, Offermans XJMW, Kubat K, Goris RJA. Whole body inflammation in trauma patients; an autopsy study. Arch Surg 1988; 123: 1519-1524.
34. Palade GE. Transport in quanta across the endothelium of blood capillaries. Anat Rec 1960; 135: 254-254.
35. Pallister I, Gosling P, Alpar K, Bradley S. Prediction of post-traumatic adult respiratory distress syndrome by albumin excretion rate eight hours after admission. J Trauma 1997; 42: 1056-1061.
36. Petty R, Pearson JD. Endothelium - the axis of vascular health and disease. J R Coll Physicians Lond 1989; 23: 92-102.
37. Preiser JC, Reper P, Vlasselaer D, Vray B, Zhang H, Metz G et al. Nitric oxide production is increased in patients after burn injury. J Trauma 1996; 40: 368-371.
38. Rixen D, Siegel JH, Espina N, Bertolini M. Plasma nitric oxide in post-trauma critical illness: a function of ‘sepsis’ and the physiological state severity classification quantifying the probability of death. Shock 1997; 1: 17-28.
39. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995; 108: 2369-2379.
40. Schmand JF, Ayala A, Morrison MH, Chaudry IH. Effects of hydroxyethyl starch after trauma-hemorrhagic shock: restoration of macrophage integrity and prevention of increased interleukin-6 levels. Crit Care Med 1995; 23: 806-814.
41. Seghaye MC, Grabitz RG, Duchateua J, Busse S, Dabritz S, Koch D et al. Inflammatory reaction and capillary leak syndrome related to cardiopulmonary bypass in neonates undergoing cardiac operations. J Thorac Cardiovasc Surg 1996; 112: 687-697.
42. Shearman CP, Gosling P, Gwynn BR, Simms MH. Systemic effects associated with intermittent claudication. A model to study biochemical aspects of vascular disease? Eur J Vasc Surg 1988; 2: 401-404.
43. Smith CT, Gosling P, Sanghera K, Green MA, Paterson IS, Shearman CP. Microproteinuria predicts the severity of systemic effects of reperfusion injury following infra renal aortic aneurysm surgery. Ann Vasc Surg 1994; 8: 1-5.
44. Staub NC, Hogg JC. Conference report of a workshop on the measurement of lung water. Crit Care Med 1980; 8: 752-759.
45. Stone HH, Fulenwider JT. Renal decapsulation in the prevention of post-ischaemia oliguria. Ann Surg 1977; 186: 343-355.
46. Szabo C, Thiemermann C. Invited opinion: the role of nitric oxide in hemorrhagic, traumatic and anaphylactic shock and thermal injury. Shock 1994; 2: 145-155.
47. Tartour E, Mathiot C, Freidman WH. Current status of interleukin-2 therapy in cancer. Biomed Pharmacother 1992; 46: 473-484.
48. Taylor AE, Moore T, Khimenko P. Microcirculatory exchange of fluid and protein and development of the third space. In: Zikria BA, Oz MO, Carlson RW eds. Reperfusion injuries and clinical capillary leak syndrome. Armonk, NY: Futura, 1994: 59-92.
49. Teelucksingh S, Padfield PL, Edwards CR. Systemic capillary leak syndrome. Q J Med 1990; 277: 515-524.
50. Traber LD, Brazeal BA, Scmiiz M. Pentafraction reduces the lung lymph response after endotoxin administration in the ovine model. Circ Shock 1992; 36: 93-98.
51. Traylor RJ, Pearl RG. Crystalloid versus colloid: all colloids are not created equal. Anaesth Analg 1996; 83: 209-212.
52. Vallance P, Monacada S. The role of nitric oxide in septic shock. New Horiz 1993; 1: 77-86.
53. Velanovich V. Crystalloid versus colloid fluid resuscitation: a meta-analysis of mortality. Surgery 1989; 105: 65-71.
54. Webb AR, Tigh D, Moss RF, Al-Saadt N, Hynd JW, Bennett ED. Advantages of a narrow range, medium molecular weight hydroxyethyl starch for volume maintenance in a porcine model of fecal peritonitis. Crit Care Med 1991; 19: 409-416.
55. Wong JM, Billiar TR. The role of inducible nitric oxide synthase in sepsis and inflammation. In: Weir EK, Archer SL, Reeves JT eds. Nitric oxide and radicals in the pulmonary vasculature. Armonk, NY: Futura, 1996: 311-328.
56. Yeh T Jr, Parmar JM, Reseyka IM. Limiting edema in neonatal cardiopulmonary bypass with narrow range molecular weight hydroxyethyl starch. J Thorac Cardiovasc Surg 1992; 104: 659-664.
57. Zaloga GP, Hughes SS. Oliguria with normal renal function. Anaethesiology 1990; 72: 589-602.
58. Zikria BA, Subarao C, Oz MC. Macromolecules reduce abnormal microvascular-vascular permeability in rat limb ischaemia-reperfusion injury. Crit Care Med 1989; 17: 1306-1309.